logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
G

Gerd R Burmester

department of rheumatology and clinical immunology

116H指数
962论文数
6.4W被引数
收录论文 244
发表时间
logo
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies菲戈替尼在真实世界中度至重度类风湿关节炎中的疗效：基于FILOSOPHY和PARROTFISH研究（超过1400例患者）的6个月疗效、患者报告结局和持续用药情况以及24个月安全性
errRheumatology and Therapy
IF2.9
err2026-07-31
err0
errOAAI
errGerd R. Burmester; James Galloway; Karen Bevers; Jérôme Avouac; Susana Romero-Yuste; Roberto F. Caporali; Neil Betteridge; Carole Van der Donckt; Thomas P. A. Debray; Ouafia Tandjaoui Bouzid; Patrick Verschueren
err分享
err收藏
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)类风湿关节炎 (FIRST-RA) 的Filgotinib初始反应研究的原理，设计和方法
errRheumatology and Therapy
IF2.9
err2026-01-12
err0
errOAAI
errGeorg Pongratz; Rieke Alten; Torsten Witte; Christine Pausch; Robert Reinhold; David Pittrow; Gerd R. Burmester
err分享
err收藏
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients更正：巴瑞替尼在类风湿关节炎中的比较疗效、停药时间及患者报告结局：欧洲患者跨国、前瞻性观察性RA-BE-REAL研究2年数据
errRheumatology and Therapy
IF2.9
err2025-11-20
err0
errOAAI
errRieke Alten; Gerd R. Burmester; Marco Matucci-Cerinic; Jean-Hugues Salmon; Andrew Östör; Khai Jing Ng; Jens Gerwien; Liliana Zaremba-Pechmann; Alan J. M. Brnabic; Bruno Fautrel
err分享
err收藏
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease乌帕替尼的安全性概况：在类风湿关节炎、银屑病关节炎、轴向脊柱关节炎、特应性皮炎和炎症性肠病中超过27,000患者年的描述性分析
errAdvances in Therapy
IF4
err2025-08-28
err0
errOAAI
errGerd R. Burmester; Atul Deodhar; Alan D. Irvine; Remo Panaccione; Kevin L. Winthrop; Ruth Ann Vleugels; Gweneth Levy; Smitha Suravaram; Hannah Palac; Lani Wegrzyn; Sharanya Ford; Sebastian Meerwein; Emma Guttman-Yassky
err分享
err收藏
Associations between childhood trauma; depression; anxiety disorders and early arthritis presence儿童创伤、抑郁、焦虑障碍与早期关节炎存在之间的关联
errFrontiers in Medicine
IF3
err2025-08-07
err0
errOAAI
errAna Konjikusic; Sarah Ohrndorf; Tanja Braun; Vivien Kluckow; Vera Höhne-Zimmer; Gabriela Schmittat; Christine Heim; Ralf Uebelhack; Kirsten Minden; Jacqueline Detert; Gerd-Rüdiger Burmester; Desiree Schaumburg
err分享
err收藏
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid ArthritisCT-P47生物类似药与参比托珠单抗的疗效和安全性比较：一项在类风湿关节炎患者中进行的随机、活性对照、双盲、III期研究的1年结果
errClinical Drug Investigation
IF2.7
err2025-07-12
err0
errOAAI
errGerd Burmester; Jakub Trefler; Artur Racewicz; Janusz Jaworski; Agnieszka Zielińska; Marek Krogulec; Sławomir Jeka; Rafał Wojciechowski; Katarzyna Kolossa; Anna Dudek; Magdalena Krajewska-Włodarczyk; Paweł Hrycaj; Piotr Adrian Klimiuk; SungHyun Kim; JeeHye Suh; GoEun Yang; YunAh Kim; YooBin Jung; GaHee Park; Josef S. Smolen
err分享
err收藏
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study疾病相关脑激活预测类风湿关节炎中TNF抑制的临床反应（PreCePra）：一项随机、多中心、双盲、安慰剂对照的III期研究
errlancet rheumatology
IF0
err2025-06-23
err0
errOAAI
errAndreas Hess; Koray Tascilar; Hanna M Schenker; Laura Konerth; Verena Schönau; Marina Sergeeva; Silke Kreitz; Jutta Prade; Sandra Strobelt; Mageshwar Selvakumar; Arnd Kleyer; Matthias Englbrecht; Axel J Hueber; Mario M Zaiss; Eugen Feist; Gerd R Burmester; Reinhard E Voll; Stephanie Finzel; Christoph Baerwald; Julie Rösch; Frank Behrens; Michaela Koehm; Jose Antonio P da Silva; Nemanja Damjanov; Arnd Dörfler; Georg Schett; Jürgen Rech
err分享
err收藏
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study
errEXPERT REVIEW OF CLINICAL IMMUNOLOGY
IF3.7
err2025-01-15
err0
PREAI
errBurmester, Gerd; Klimiuk, Piotr Adrian; Trefler, Jakub; Jaworski, Janusz; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Lee, Hyunseung; Jang, Jiyoung; Hwang, Chankyoung; Lee, Hojae; Smolen, Josef S.
err分享
err收藏
Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies (vol 44, pg 1233, 2024)
errRHEUMATOLOGY INTERNATIONAL
IF2.9
err2024-10-14
err0
errOAAI
errKadam, Esha; Javaid, Mahnoor; Sen, Parikshit; Saha, Sreoshy; Ziade, Nelly; Day, Jessica; Wincup, Chris; Andreoli, Laura; Parodis, Ioannis; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki; Dey, Dzifa; Cavagna, Lorenzo; Chatterjee, Tulika; Knitza, Johannes; Wang, Guochun; Dalbeth, Nicola; Velikova, Tsvetelina; Battista, Simone; Cheng, Karen; Boyd, Peter; Kobert, Linda; Gracia-Ramos, Abraham Edgar; Mittal, Srijan; Makol, Ashima; Gutierrez, Carlos Enrique Toro; Caballero-Uribe, Carlo V.; Kuwana, Masataka; Burmester, Gerd-Ruediger; Guillemin, Francis; Nikiphorou, Elena; Chinoy, Hector; Makhloufi, Chafia Dahou; Agarwal, Vikas; Gupta, Latika
err分享
err收藏
Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination
errJOURNAL OF MEDICAL VIROLOGY
IF4.6
err2024-07-05
err0
errOAAI
errMei, Henrik E.; Schulz, Axel Ronald; Hirseland, Heike; Diekmann, Lisa-Marie; Habermann, Elisa; ten Hagen, Alexander; Albach, Fredrik; Burmester, Gerd-Ruediger; Gruetzkau, Andreas; Biesen, Robert
err分享
err收藏
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open-label, single-dose phase I study
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2024-06-21
err1
errOAAI
errYu, Kyung-Sang; Ryu, Hyunwook; Shin, Dongseong; Park, Minkyu; Hwang, Jungi; Moon, Seol Ju; Kim, Min-Gul; Keystone, Edward; Smolen, Josef S.; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jang, Jiyoung; Yang, Goeun; Bae, Jihun; Lee, Jaeyong; Burmester, Gerd R.
err分享
err收藏
CHARACTERIZATION OF PRECLINICAL RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS BY CLINICAL AND IMAGING PARAMETERS AND THEIR POTENTIAL ROLE IN THE PREDICTION OF ARTHRITIS通过临床和影像参数对类风湿关节炎和银屑病关节炎的预临床阶段进行表征，及其在预测关节炎方面的潜在作用
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errNendel, N.; Klotsche, J.; Schmittat, G.; Backhaus, M.; Kroenke, G.; Burmester, G. R.; Kokolakis, G.; Ohrndorf, S.
err分享
err收藏
TO OPTIMIZE THE DIAGNOSTIC PROCESS OF RHEUMATIC DISEASES AFFECTING THE HANDS USING FOI为了优化影响手部的风湿病的诊断过程，采用FOI技术。
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errStumper, N.; Berger, J.; Gedat, E.; Hoff, P.; Schmittat, G.; Burmester, G. R.; Kroenke, G.; Backhaus, M.; Haugen, I. K.; Ohrndorf, S.
err分享
err收藏
PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)TREATED WITH FILGOTINIB FOR UPTO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH患者报告结局（PROs）、疾病活动度和安全性：接受Filgotinib治疗达18个月的1,177例类风湿关节炎（RA）患者的数据，结果来自FILOSOPHY和PARROTFISH研究的期中分析。
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errAvouac, J.; Burmester, G. R.; Caporali, R. F.; Debray, T. P. A.; De Leonardis, F.; Galloway, J.; Betteridge, N.; Bevers, K.; Romero-Yuste, S.; Zignani, M.; Verschueren, P.
err分享
err收藏
PHARMACOKINETICS, USABILITY AND SAFETY OF TOCILIZUMAB BIOSIMILAR (CT-P47) ADMINISTERED SUBCUTANEOUSLY BY AUTO-INJECTOR OR PRE- FILLED SYRINGE托珠单抗生物类似药（CT-P47）经自动注射器或预充式注射器皮下给药的药代动力学、可用性和安全性
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errKeystone, E.; Burmester, G. R.; Smolen, J. S.; Yu, K. S.; Ryu, H.; Shin, D.; Park, M.; Hwang, J.; Moon, S. J.; Kim, M.; Klimiuk, P. A.; Trefler, J.; Jaworski, J.; Kim, S. H.; Bae, Y.; Jeon, D.; Lee, H.; Jang, J.; Bae, J.
err分享
err收藏
SAFETY OF UPADACITINIB ACROSS RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS ENCOMPASSING 15,000 PATIENT-YEARS OF CLINICAL TRIAL DATA乌帕替尼在类风湿关节炎、银屑病关节炎和轴向脊柱关节炎中的安全性：涵盖15,000患者年的临床试验数据
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errBurmester, G. R.; Cohen, S. B.; Deodhar, A.; Mysler, E.; Rubbert-Roth, A.; Tanaka, Y.; Winthrop, K. L.; Nakasato, P.; Coombs, D.; Gara, A.; Khan, N.; Kovacs, B.; Meerwein, S.; Curtis, J. R.
err分享
err收藏
SIMILAR EFFICACY, SAFETY, AND IMMUNOGENICITY OFTOCILIZUMAB BIOSIMILAR (CT-P47) AND REFERENCE TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: WEEK 32 RESULTS FROM THE PHASE III SINGLE TRANSITION STUDY中度至重度活动性类风湿关节炎患者中，曲妥珠单抗生物类似药（CT-P47）与参比曲妥珠单抗具有相似的有效性、安全性和免疫原性：III期单过渡研究的第32周结果
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errSmolen, J. S.; Trefler, J.; Racewicz, A.; Jaworski, J.; Zielinska, A.; Krogulec, M.; Jeka, S.; Wojciechowski, R.; Kolossa, K.; Dudek, A.; Krajewska-Wlodarczyk, M.; Hrycaj, P.; Klimiuk, P. A.; Burmester, G. R.; Kim, S. H.; Bae, Y.; Jeon, D.; Yang, G.; Jung, Y.; Hong, J.; Keystone, E.
err分享
err收藏
PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSEDTOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH INTRAVENOUS EU-APPROVEDTOCILIZUMAB AND US-LICENSEDTOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND,THREE-ARM, SINGLE-DOSE STUDY IN HEALTHY JAPANESE SUBJECTSCT-P47（一种拟定的托珠单抗生物类似药）的药代动力学和安全性研究，与静脉用欧盟批准的托珠单抗和获美国许可的托珠单抗进行对比；一项在健康日本受试者中进行的I期、随机、双盲、三臂、单剂量研究
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errHaranaka, M.; Eto, T.; Tanaka, T.; Yazawa, R.; Burmester, G. R.; Keystone, E.; Kim, S. H.; Bae, Y.; Suh, J.; Kim, Y.; Lee, J.; Smolen, J. S.
err分享
err收藏
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Upadacitinib治疗类风湿性关节炎和对常规合成的改善疾病的抗风湿药物反应不足: 5年的疗效和安全性 (SELECT-NEXT)
errJOURNAL OF RHEUMATOLOGY
IF3.4
err2024-04-15
err2
PREAI
errBurmester, Gerd R.; van den Bosch, Filip; Tesser, John; Shmagel, Anna; Liu, Yanxi; Khan, Nasser; Camp, Heidi S.; Kivitz, Alan
err分享
err收藏
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
errRHEUMATOLOGY INTERNATIONAL
IF2.9
err2024-04-12
err1
errOAAI
errKadam, Esha; Javaid, Mahnoor; Sen, Parikshit; Saha, Sreoshy; Ziade, Nelly; Day, Jessica; Wincup, Chris; Andreoli, Laura; Parodis, Ioannis; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki; Dey, Dzifa; Cavagna, Lorenzo; Chatterjee, Tulika; Knitza, Johannes; Wang, Guochun; Dalbeth, Nicola; Velikova, Tsvetelina; Battista, Simone; Cheng, Karen; Boyd, Peter; Kobert, Linda; Gracia-Ramos, Abraham Edgar; Mittal, Srijan; Makol, Ashima; Gutierrez, Carlos Enrique Toro; Uribe, Carlo V. Caballero; Kuwana, Masataka; Burmester, Gerd-Ruediger; Guillemin, Francis; Nikiphorou, Elena; Chinoy, Hector; Aggarwal, Vikas; Gupta, Latika
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
N
Naveed Sattar
H 指数: 204 · 论文数: 2.2K
S
Stefan Schreiber
H 指数: 192 · 论文数: 1.9K
P
Paul Emery
H 指数: 158 · 论文数: 1.6K
D
Désirée van der Heijde
H 指数: 158 · 论文数: 1.3K
G
Georg Schett
H 指数: 154 · 论文数: 1.7K
查看更多